Blood cancers require advanced, effective, and targeted treatment solutions. Ibrunat (Ibrutinib) 140mg Capsules by Cordium Pharmaceuticals Pvt Ltd is a trusted targeted therapy designed to help patients diagnosed with various B-cell cancers and hematological malignancies.
As global demand for affordable oncology medicines continues to rise across Kenya, Nigeria, Ghana, Philippines, Vietnam, UAE, Saudi Arabia, Uzbekistan, Kazakhstan, USA, UK, and South Africa, Ibrunat has become an important treatment option for healthcare providers and patients worldwide.
What is Ibrunat (Ibrutinib) 140mg?
Ibrunat contains Ibrutinib 140mg, an oral targeted anti-cancer medicine classified as a Bruton's Tyrosine Kinase (BTK) inhibitor.
It works by blocking signals that help cancer cells survive and multiply, slowing disease progression and improving treatment outcomes.
Medical Uses of Ibrunat (Ibrutinib) 140mg Capsules
Doctors may prescribe Ibrunat for the treatment of:
✅ Chronic Lymphocytic Leukemia (CLL)
A common blood cancer affecting white blood cells.
✅ Small Lymphocytic Lymphoma (SLL)
A slow-growing cancer closely related to CLL.
✅ Mantle Cell Lymphoma (MCL)
An aggressive type of non-Hodgkin lymphoma.
✅ Waldenström Macroglobulinemia (WM)
A rare blood cancer affecting plasma cells.
✅ Marginal Zone Lymphoma (MZL)
A cancer that develops in lymphoid tissue.
✅ Chronic Graft-versus-Host Disease (cGVHD)
In certain patients after stem cell transplantation.
Important: Treatment should only be initiated under the supervision of a qualified oncologist or hematologist.
How Does Ibrutinib Work?
Ibrutinib blocks Bruton's Tyrosine Kinase (BTK), a protein responsible for helping cancer cells grow and survive.
Benefits of BTK Inhibition:
Helps slow cancer progression
Reduces abnormal B-cell activity
Improves treatment response
Supports long-term disease management
Convenient oral capsule administration
Key Benefits of Ibrunat (Ibrutinib) 140mg Capsules
Why healthcare professionals choose Ibrunat:
✔️ Targeted cancer therapy
✔️ Oral capsule for convenient use
✔️ Proven efficacy in multiple blood cancers
✔️ Supports long-term disease control
✔️ Globally trusted active ingredient
✔️ Manufactured under stringent quality standards
Recommended Dosage
The dosage varies depending on:
Type of blood cancer
Patient's age
Overall health condition
Liver function
Concurrent medications
Do not self-medicate. Always follow your doctor's prescription.
Possible Side Effects
Like all cancer medicines, Ibrutinib may cause side effects.
Common side effects include:
Fatigue
Diarrhea
Muscle and joint pain
Nausea
Rash
Bruising
Low blood counts
Increased risk of infections
High blood pressure
Seek immediate medical attention if serious side effects occur.
Precautions Before Using Ibrunat
Inform your doctor if you have:
Bleeding disorders
Heart disease
High blood pressure
Liver disease
Active infections
Recent surgery
Pregnancy or breastfeeding concerns
Patients should avoid taking certain medications and supplements without medical consultation.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Cordium Pharmaceuticals Pvt Ltd is committed to delivering high-quality, affordable specialty medicines worldwide.
Our strengths:
WHO-GMP quality standards
Reliable global supply chain
Competitive pricing
Oncology medicine expertise
Export support for international markets
Regulatory documentation assistance
Global Supply Markets We Serve
Africa
🇰🇪 Kenya
🇳🇬 Nigeria
🇬🇭 Ghana
🇿🇦 South Africa
Asia
🇵🇭 Philippines
🇻🇳 Vietnam
🇺🇿 Uzbekistan
🇰🇿 Kazakhstan
Middle East
🇦🇪 United Arab Emirates
🇸🇦 Saudi Arabia
Europe & North America
🇬🇧 United Kingdom
🇺🇸 United States
Frequently Asked Questions (FAQs)
Is Ibrunat the same as Ibrutinib?
Ibrunat is a brand containing the active ingredient Ibrutinib 140mg.
Is Ibrunat chemotherapy?
No. Ibrunat is a targeted therapy medicine known as a BTK inhibitor.
Can Ibrunat cure blood cancer?
Ibrunat helps manage and control certain blood cancers but is not considered a universal cure. Treatment outcomes vary by patient.
Is a prescription required?
Yes. Ibrunat should only be used under the supervision of a licensed healthcare professional.
As global demand for affordable oncology medicines continues to rise across Kenya, Nigeria, Ghana, Philippines, Vietnam, UAE, Saudi Arabia, Uzbekistan, Kazakhstan, USA, UK, and South Africa, Ibrunat has become an important treatment option for healthcare providers and patients worldwide.
What is Ibrunat (Ibrutinib) 140mg?
Ibrunat contains Ibrutinib 140mg, an oral targeted anti-cancer medicine classified as a Bruton's Tyrosine Kinase (BTK) inhibitor.
It works by blocking signals that help cancer cells survive and multiply, slowing disease progression and improving treatment outcomes.
Medical Uses of Ibrunat (Ibrutinib) 140mg Capsules
Doctors may prescribe Ibrunat for the treatment of:
✅ Chronic Lymphocytic Leukemia (CLL)
A common blood cancer affecting white blood cells.
✅ Small Lymphocytic Lymphoma (SLL)
A slow-growing cancer closely related to CLL.
✅ Mantle Cell Lymphoma (MCL)
An aggressive type of non-Hodgkin lymphoma.
✅ Waldenström Macroglobulinemia (WM)
A rare blood cancer affecting plasma cells.
✅ Marginal Zone Lymphoma (MZL)
A cancer that develops in lymphoid tissue.
✅ Chronic Graft-versus-Host Disease (cGVHD)
In certain patients after stem cell transplantation.
Important: Treatment should only be initiated under the supervision of a qualified oncologist or hematologist.
How Does Ibrutinib Work?
Ibrutinib blocks Bruton's Tyrosine Kinase (BTK), a protein responsible for helping cancer cells grow and survive.
Benefits of BTK Inhibition:
Helps slow cancer progression
Reduces abnormal B-cell activity
Improves treatment response
Supports long-term disease management
Convenient oral capsule administration
Key Benefits of Ibrunat (Ibrutinib) 140mg Capsules
Why healthcare professionals choose Ibrunat:
✔️ Targeted cancer therapy
✔️ Oral capsule for convenient use
✔️ Proven efficacy in multiple blood cancers
✔️ Supports long-term disease control
✔️ Globally trusted active ingredient
✔️ Manufactured under stringent quality standards
Recommended Dosage
The dosage varies depending on:
Type of blood cancer
Patient's age
Overall health condition
Liver function
Concurrent medications
Do not self-medicate. Always follow your doctor's prescription.
Possible Side Effects
Like all cancer medicines, Ibrutinib may cause side effects.
Common side effects include:
Fatigue
Diarrhea
Muscle and joint pain
Nausea
Rash
Bruising
Low blood counts
Increased risk of infections
High blood pressure
Seek immediate medical attention if serious side effects occur.
Precautions Before Using Ibrunat
Inform your doctor if you have:
Bleeding disorders
Heart disease
High blood pressure
Liver disease
Active infections
Recent surgery
Pregnancy or breastfeeding concerns
Patients should avoid taking certain medications and supplements without medical consultation.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Cordium Pharmaceuticals Pvt Ltd is committed to delivering high-quality, affordable specialty medicines worldwide.
Our strengths:
WHO-GMP quality standards
Reliable global supply chain
Competitive pricing
Oncology medicine expertise
Export support for international markets
Regulatory documentation assistance
Global Supply Markets We Serve
Africa
🇰🇪 Kenya
🇳🇬 Nigeria
🇬🇭 Ghana
🇿🇦 South Africa
Asia
🇵🇭 Philippines
🇻🇳 Vietnam
🇺🇿 Uzbekistan
🇰🇿 Kazakhstan
Middle East
🇦🇪 United Arab Emirates
🇸🇦 Saudi Arabia
Europe & North America
🇬🇧 United Kingdom
🇺🇸 United States
Frequently Asked Questions (FAQs)
Is Ibrunat the same as Ibrutinib?
Ibrunat is a brand containing the active ingredient Ibrutinib 140mg.
Is Ibrunat chemotherapy?
No. Ibrunat is a targeted therapy medicine known as a BTK inhibitor.
Can Ibrunat cure blood cancer?
Ibrunat helps manage and control certain blood cancers but is not considered a universal cure. Treatment outcomes vary by patient.
Is a prescription required?
Yes. Ibrunat should only be used under the supervision of a licensed healthcare professional.
Keywords
